Panagiotis Tsourapas - 11 Feb 2026 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
COO, Eur., APac, Afr Eur, Skin
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Issuer symbol
CL
Transactions as of
11 Feb 2026
Net transactions value
-$957,936
Form type
4
Filing time
13 Feb 2026, 16:25:19 UTC
Previous filing
05 Dec 2025
Next filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tsourapas Panagiotis COO, Eur., APac, Afr Eur, Skin C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK /s/ Kristine Hutchinson, Attorney-in-Fact 13 Feb 2026 0001576945

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $2,674,350 +35,000 +336% $76.41 45,415 11 Feb 2026 Direct F1
transaction CL Common Stock Sale $3,311,326 -35,000 -77% $94.61 10,415 11 Feb 2026 Direct F2, F3
transaction CL Common Stock Options Exercise $1,146,150 +15,000 +144% $76.41 25,415 12 Feb 2026 Direct F1
transaction CL Common Stock Sale $1,467,111 -15,000 -59% $97.81 10,415 12 Feb 2026 Direct F2, F4
holding CL Common Stock 4,568 11 Feb 2026 By Issuer's 401(k) Plan Trustee
holding CL Common Stock 60,745 11 Feb 2026 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -35,000 -50% $0.000000 34,938 11 Feb 2026 Common Stock 35,000 $76.41 Direct F1, F5
transaction CL Stock Option (Right to Buy) Options Exercise $0 -15,000 -43% $0.000000 19,938 12 Feb 2026 Common Stock 15,000 $76.41 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.